MarxR. Overscreening for women’s cancer: time for change. Med Decis Making. 2022;42(3):1041-1044.
2.
HaasJSBarlowWESchapiraMM, et al. Primary care providers' beliefs and recommendations and use of screening mammography by their patients. J Gen Intern Med. 2017;32(4):449–57.
3.
OgdenSNGlanzKSchapiraMMBocageCEriksenWRendleKA. Patient perspectives on primary HPV testing for routine cervical cancer screening. J Gen Intern Med. 2020;35(3):956–8.
4.
AlberJMBrewerNTMelvinC, et al. Reducing overuse of cervical cancer screening: a systematic review. Prev Med. 2018;116:51–9.
5.
MossJLRoySShenC, et al. Geographic variation in overscreening for colorectal, cervical, and breast cancer among older adults. JAMA Netw Open. 2020;3(7):e2011645.
6.
NortonWEChambersDAKramerBS. Conceptualizing de-implementation in cancer care delivery. J Clin Oncol. 2019;37(2):93–6.
7.
CurrySJKristAHOwensDK, et al. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(7):674–86.
8.
MelnikowJHendersonJTBurdaBUSengerCADurbinSWeyrichMS. Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;320(7):687–705.
9.
FonthamETHWolfAMDChurchTR, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020;70(5):321–46.
10.
SiuAL, US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164(4):279–96.
11.
CroswellJMRansohoffDFKramerBS. Principles of cancer screening: lessons from history and study design issues. Semin Oncol. 2010;37(3):202–15.
12.
OeffingerKCFonthamETEtzioniR, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599–614.
13.
SaslowDSolomonDLawsonHW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62(3):147–72.
14.
SchererLDShafferVACaverlyTDeWittJZikmund-FisherBJ. Medical maximizing-minimizing predicts patient preferences for high- and low-benefit care. Med Decis Making. 2020;40(1):72–80.
15.
DriedgerSMAnnableGBrouwersMTurnerDMaierR. Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions. BMC Cancer. 2017;17(1):647.
16.
WienerRSKoppelmanEBoltonR, et al. Patient and clinician perspectives on shared decision-making in early adopting lung cancer screening programs: a qualitative study. J Gen Intern Med. 2018;33(7):1035–42.
17.
AugustssonHIngvarssonSNilsenP, et al. Determinants for the use and de-implementation of low-value care in health care: a scoping review. Implement Sci Commun. 2021;2(1):13.
18.
NortonWEChambersDA. Unpacking the complexities of de-implementing inappropriate health interventions. Implement Sci. 2020;15(1):2.
19.
NilsenP ISHassonHvon Thiele SchwarzUAugustssonH. Theories, models, and frameworks for de-implementation of low-value care: a scoping review of the literature. Theories, models, and frameworks for de-implementation of low-value care: a scoping review of the literature. Implement Res Pract. 2020. https://doi.org/10.1177/2633489520953762
20.
YoongSLHallAStaceyF, et al. Nudge strategies to improve healthcare providers’ implementation of evidence-based guidelines, policies and practices: a systematic review of trials included within Cochrane systematic reviews. Implement Sci. 2020;15(1):50.
21.
PatelMSNavatheASLiaoJM. Using nudges to improve value by increasing imaging-based cancer screening. J Am Coll Radiol. 2020;17(1 pt A):38–41.
